TickerFacts.

Idexx Laboratories Inc (IDXX): EPS (Basic)

Annual figures by period end, from SEC filings.

Stock splits: 2-for-1, first reflected in a filing dated 2015-07-30. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

$13.17
Year ended 2025-12-31
+17.5%
3-year compound annual growth
+14.1%
5-year compound annual growth
+20.3%
10-year compound annual growth
2008-12-31: $1.942009-12-31: $2.082010-12-31: $2.452011-12-31: $2.852012-12-31: $3.242013-12-31: $1.772014-12-31: $1.822015-12-31: $2.072016-12-31: $2.472017-12-31: $3.002018-12-31: $4.342019-12-31: $4.972020-12-31: $6.822021-12-31: $8.742022-12-31: $8.122023-12-31: $10.172024-12-31: $10.772025-12-31: $13.17$13.17
2008-12-31 EPS (Basic) (USD per share) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedEPS (Basic)Change YoYSource filing
2025-12-31$13.17+22.3%2026-02-20, From 2025-01-01
2024-12-31$10.77+5.9%2026-02-20, From 2024-01-01
2023-12-31$10.17+25.2%2026-02-20, From 2023-01-01
2022-12-31$8.12-7.1%2025-02-21, From 2022-01-01
2021-12-31$8.74+28.2%2024-02-22, From 2021-01-01
2020-12-31$6.82+37.2%2023-02-16, From 2020-01-01
2019-12-31$4.97+14.5%2022-02-16, From 2019-01-01
2018-12-31$4.34+44.7%2021-02-12, From 2018-01-01
2017-12-31$3.00+21.5%2020-02-14, From 2017-01-01
2016-12-31$2.47+19.3%2019-02-15, From 2016-01-01
2015-12-31$2.07+13.7%2018-02-16, From 2015-01-01
2014-12-31$1.82+2.8%2017-02-17, From 2014-01-01
2013-12-31$1.77n/c2016-02-17, From 2013-01-01
2012-12-31$3.24+13.7%2015-02-17, From 2012-01-01
2011-12-31$2.85+16.3%2014-02-18, From 2011-01-01
2010-12-31$2.45+17.8%2013-02-19, From 2010-01-01
2009-12-31$2.08+7.2%2012-02-17, From 2009-01-01
2008-12-31$1.94n/a2011-02-22, From 2008-01-01

EPS (Basic) at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Basic)Change YoY
Idexx Laboratories Inc (IDXX)2025-12-31$13.17+22.3%
QuidelOrtho Corp (QDEL)2025-12-28-$16.69n/m
Lantheus Holdings, Inc. (LNTH)2025-12-31$3.46-23.5%
Neogen Corp (NEOG)2026-05-31-$0.04n/m
Myriad Genetics Inc (MYGN)2025-12-31-$3.95n/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$3.81n/m
Alpha Teknova, Inc. (TKNO)2025-12-31-$0.32n/m
Immucell Corp (ICCC)2025-12-31-$0.12n/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$0.37n/m

Compare IDXX, QDEL, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗